Study: Does Breast Density Increase Breast Cancer Risk?
Previous studies suggest that women with denser breast tissue have an increased risk of breast cancer. However, these studies used data from mammograms that "cannot accurately measure breast density," says Wenlian Zhu, PhD, a research associate in the Johns Hopkins University School of Medicine and an author of the study.
"Our research may help dispel the assertion that breast density alone is something women should be worried about with regard to their breast cancer risk, and it may help minimise confusion and unnecessary concern," Dr. Zhu explains.
See Also: RSNA15: Study: Breast Density Alone Not a Risk Factor for Cancer
To confirm whether breast density is an independent risk factor for breast cancer, the researchers examined 3D, T1-weighted MRI breast scans done between 2007 and 2014 on 410 patients with invasive cancer in one breast, 73 patients with ductal carcinoma in situ, and 361 women with no evidence of breast cancer. The imaging technique used offers high contrast between fatty and dense glandular breast tissues, providing a more accurate measurement of breast density.
See Also: Mammographic Screening for Women with Dense Breasts
In addition, the researchers used MRI scans to assess adiposity using measurements of the fatty tissue thickness in the upper abdomen right beneath the breast. Then, investigators searched for links among breast cancer and breast density, body adiposity, and subjects' ages. Their analysis revealed strong correlation between both age and adiposity with breast cancer. However, the correlation between breast cancer and breast density alone was insignificant.
Dr. Zhu says one likely explanation for their finding is that women with the densest breasts tended to be young and lean, both factors aligned with lower breast cancer risk.
She cautions that this study did not specifically examine the interactions among age, adiposity and breast density for older women. Testing whether breast density is associated with breast cancer in this population will be the subject of future research, Dr. Zhu adds.
Source: Johns Hopkins Medicine
Image credit: Wikimedia Commons
Published on : Wed, 9 Dec 2015
About the Affirm® breast biopsy guidance system Our passion to offer innovative interventional tools that advance breast health fueled the development of the Affirm breast biopsy guidance system. This simple add-on to any Hologic 3D Mammography™-capable...
Transform the breast imaging patient experience The SmartCurve system provides a curved compression surface that offers a more comfortable patient experience without compromising image quality, exam time, dose or workflow.1 The SmartCurve system is...
Expertly designed to optimize productivity ARIETTA 65 has been designed to perform quick and precise diagnosis in general imaging without compromising on productivity and workflow. This ultrasound platform combines productivity, enhanced tools...
Radiation Dose Monitor (RDM) Touch is a DACS (Dose Archiving and Communication System) software solution for collecting, controlling, analyzing and optimizing radiation doses delivered to patients during medical imaging examinations. Designed for...
Better detection. Clinically superior. Low dose.** What if we could find breast cancers earlier? See lesions more clearly? Reduce the number of unnecessary biopsies? Questions like these inspired Hologic researchers and scientists to develop Hologic...